PDSB

PDS BIOTECHNOLOGY CORP

PDSB·70465T107·US·Common Stock·Healthcare - Biotechnology-13D/G

PDSB (PDS BIOTECHNOLOGY CORP) is held by 34 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.5M), Focus Partners Wealth ($565,822), Quantinno Capital Management LP ($565,822). Net institutional sentiment: Bullish.

34
Holders
(2 Elite)
$6.1M
Total Value
77% (26)
Consensus
20 buying - 6 selling
13F: Insider & Congress: Updated regularly
PDSB

Smart Money Verdict

View all
Loading verdict
Held by 34 funds
2 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Nov 14, 2025 · Congress none

ActivistARArmistice Capital, LLC0.0%Nov 14, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.7M(+4.2%)$1.5M0.0%-67.10%
18
New
642,177$565,8220.0%-74.67%
34
New
642,177$565,8220.0%-74.67%
34
Increased
607,639(+9.7%)$535,3910.0%-85.53%
18
Decreased
587,139(-11.1%)$517,4100.0%-93.20%
0
Increased
357,144(+16.2%)$314,6440.0%-68.09%
27
New
323,801$285,3010.0%-74.67%
36
Increased
313,922(+7904.1%)$276,5970.0%-75.32%
26
Unchanged
300,000$264,3300.0%-88.86%
0
New
279,664$246,4120.0%-74.67%
35
Increased
252,200(+14.2%)$222,2130.0%-78.58%
26
New
147,171$129,5100.0%-74.67%
31
Unchanged
133,333$117,4800.0%-94.97%
0
Increased
126,502(+16.2%)$111,4610.0%-92.20%
17
Decreased
109,000(-1.4%)$96,0400.0%-73.15%
0
Increased
92,997(+2.4%)$81,9400.0%-93.88%
22
Decreased
68,491(-1.2%)$60,3480.0%-92.63%
0
Increased
36,328(+64.7%)$32,0090.0%-82.69%
20
Increased
33,819(+230.4%)$29,7980.0%-80.18%
21
Decreased
33,098(-8.6%)$29,1630.0%-75.39%
0

Showing 1-20 of 35

1 / 2
PDSBPDSBPDS BIOTECHNOLOGY CORP

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used